CSS LLC’s ChemoCentryx, Inc. CCXI Stock Holding History

CSS LLC’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,912	Closed	-$320K	–	1318
2022 Q2	$320K	Hold	12,912	–	–	0.01%	698
2022 Q1	$324K	Buy	12,912 +3,420	+36%	+$96.1K	0.01%	728
2021 Q4	$346K	Sell	9,492 -41,641	-81%	-$1.46M	0.01%	774
2021 Q3	$874K	Buy	51,133 +38,533	+306%	+$600K	0.04%	442
2021 Q2	$169K	Buy	+12,600	New	+$310K	0.01%	873
2020 Q4	–	Sell	-5,893	Closed	-$337K	–	988
2020 Q3	$323K	Buy	+5,893	New	+$317K	0.02%	494

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

CSS LLC's CCXI Position: Q3 2022 in Review

CSS LLC sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 12,912 shares — an estimated $320K sold.

CSS LLC first reported a position in CCXI in Q3 2020 and held it in 6 quarters. The position peaked at $874K in Q3 2021. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

CSS LLC reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
CSS LLC sold 12,912 ChemoCentryx, Inc. shares in Q3 2022, an estimated $320K.
CSS LLC first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 6 quarters.
CSS LLC's ChemoCentryx, Inc. position peaked at $874K in Q3 2021.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on CSS LLC's 13F filing for Q3 2022, filed 14 Nov 2022.